BiomX
PHGE
12 hedge funds and large institutions have $1.93M invested in BiomX in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
68% more capital invested
Capital invested by funds: $1.15M → $1.93M (+$780K)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.01% less ownership
Funds ownership: 0.11% → 0.1% (-0.01%)
8% less funds holding
Funds holding: 13 → 12 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$116K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$51.3K |
| 3 |
Renaissance Technologies
New York
|
+$13K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.1K |
| 5 |
Walleye Capital
New York
|
+$2.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$79.1K |
| 2 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$25.3K |
| 3 |
Jane Street
New York
|
-$11.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.91K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$1.98K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $964K | +$116K | +1,831 | +12% |
|
|
JJ
2
Johnson & Johnson
New Brunswick,
New Jersey
| $651K | – | – | – |
|
|
MI
3
MMCAP International
Grand Cayman,
Cayman Islands
| $185K | -$25.3K | -401 | -11% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $59.7K | +$51.3K | +811 | +372% |
|
|
5
Renaissance Technologies
New York
| $24K | +$13K | +205 | +99% |
|
|
BCM
6
Bridgeway Capital Management
Houston,
Texas
| $15.1K | – | – | – |
|
|
7
Millennium Management
New York
| $10K | -$79.1K | -1,251 | -88% |
|
|
8
Citadel Advisors
Miami,
Florida
| $9.29K | +$10.1K | +160 | New |
|
|
9
Walleye Capital
New York
| $6.42K | +$2.53K | +40 | +56% |
|
10
Walleye Trading
New York
| $3.18K | – | – | – |
|
11
BlackRock
New York
| $1.75K | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| $916 | -$8.91K | -141 | -90% |
|
|
13
Jane Street
New York
| – | -$11.2K | -315 | Closed |
|
|
TSS
14
Two Sigma Securities
New York
| – | -$1.98K | -56 | Closed |
|
PHGE Hedge Fund Activity: Q1 2023 in Review
12 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q1 2023, worth a combined $1.93M — up 68% from $1.15M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHGE and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was OrbiMed, adding an estimated $116K. The largest seller was Millennium Management, cutting an estimated $79.1K.
- 12 institutional investors held BiomX (PHGE) as of Q1 2023, down from 13 in Q4 2022.
- Funds reported $1.93M of BiomX stock for Q1 2023, up 68% quarter-over-quarter.
- 1 fund opened new BiomX positions in Q1 2023 and 2 closed out, a net change of -1 holder.
- The largest BiomX buyer in Q1 2023 was OrbiMed, an estimated $116K added.
- The largest BiomX seller in Q1 2023 was Millennium Management, an estimated $79.1K sold.
Based on aggregated 13F filings for Q1 2023.